Profiling STING and TLR-Targeted Therapies in Preclinical Models
Time: 1:15 pm
day: Conference Day 1
Details:
- Focus on BRGSF-HIS hCD34+ reconstituted mice featuring human lymphoid and myeloid compartments and STING humanized mouse models
- Characterization of the immune response
- Showcase of assessment of STING and TLR targeting agents in these models
